Back
Open Access

Key takeaways: addressing residual cardiovascular risk with proven therapies

Session: From risk assessment to action: the role of icosapent ethyl in cardiovascular risk management
Topic: Secondary Prevention
Speaker: Professor G. De Ferrari (Turin, IT)
Sponsored by Amarin
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Professor Gaetano Maria De Ferrari

University of Turin, Turin (Italy)
19 presentations
0 follower

3 more presentations in this session

Clinical Case Introduction

Speaker: Professor V. Aboyans (Limoges, FR)

Access
Like
Thumbnail

U-Prevent: a personalized approach to cardiovascular risk management

Speaker: Doctor J. Dorresteijn (Utrecht, NL)

Access
Like
Thumbnail

Understanding the clinical benefit of icosapent ethyl: insights from REDUCE-IT

Speaker: Doctor H. Contractor (Manchester, GB)

Access
Like
Thumbnail

Access the full session

From risk assessment to action: the role of icosapent ethyl in cardiovascular risk management

Speakers: Professor G. De Ferrari, Professor V. Aboyans, Doctor J. Dorresteijn, Doctor H. Contractor
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources